[Well-differentiated thyroid carcinoma]

Area of Science:

• Endocrinology
• Oncology
• Nuclear Medicine

Context:

• Well-differentiated thyroid carcinoma presents diagnostic challenges, with radio-isotope scanning often revealing cold or indeterminate nodules.
• Fine needle aspiration shows variable concordance with histological findings.

Purpose:

• To evaluate the efficacy of radioactive iodine (131I) ablation for thyroid remnants in well-differentiated thyroid carcinoma.
• To assess the required dosage and frequency of 131I for successful ablation.

Summary:

• Eighteen cases of well-differentiated thyroid carcinoma were analyzed, including papillary, mixed, and follicular subtypes.
• Thyroid remnants were detected in all patients post-surgery and treated with 131I ablation.
• Initial 30 millicurie (mCi) doses of 131I were frequently insufficient, necessitating a second dose for effective ablation.
• Higher doses (150-170 mCi) were used for cases with regional spread, achieving clinical remission in 14 patients.
• Follow-up included ultrasonography and total body 131I scans to monitor treatment outcomes.

Impact:

• This study highlights the need for potentially higher or repeated radioactive iodine doses for complete ablation of thyroid remnants in differentiated thyroid cancer.
• Optimized 131I dosing strategies can improve clinical remission rates and long-term management of thyroid cancer.
• The findings support the use of serial imaging and targeted 131I therapy in managing differentiated thyroid carcinoma.